[GSK] YoY Quarter Result on 31-Dec-2017 [#Q4]

Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -145.05%
YoY- -312.45%
Quarter Report
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 8,739,000 8,899,000 8,197,000 7,639,000 7,586,000 6,286,000 6,186,000 5.92%
PBT 821,000 1,711,000 1,374,000 442,000 423,000 -416,000 531,000 7.52%
Tax -18,000 194,000 74,000 805,000 106,000 12,000 -494,000 -42.39%
NP 677,000 1,299,000 1,215,000 -546,000 257,000 -354,000 1,033,000 -6.79%
Tax Rate 2.19% -11.34% -5.39% -182.13% -25.06% - 93.03% -
Total Cost 8,062,000 7,600,000 6,982,000 8,185,000 7,329,000 6,640,000 5,153,000 7.73%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 7.75 14.60 14.82 -7.15 3.39 -5.63 16.70 -12.00%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.17 0.33 0.31 -0.14 0.07 -0.09 0.27 -7.41%
EPS Diluted 0.17 0.32 0.31 -0.14 0.07 -0.09 0.27 -7.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ & YoY figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.